The advanced therapies industry is heavily engaged in capitalizing upon the extensive ‘proof of concept’ gained through the success of mRNA-based COVID-19 vaccines. Novel therapeutic applications in major disease areas, including oncology, continue to show promise in preclinical and early clinical studies, yet challenges remain.
Here, a panel of thought-leaders from the mRNA field will consider the ever-expanding reach of mRNA technology, exploring at a high level how and where it will impact the advanced therapies space moving forward. The panel will then dive deeper into specific trends, issues, and innovations in mRNA processing (particularly downstream) and analytical development, discussing key areas for improvement and corresponding solutions.
Attend this webinar for: